Bayer Lung Cancer Drug Lands Speedy FDA Nod
Digest more
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Merck on Tuesday said its drug, Winrevair, met the primary endpoint in a Phase 2 study in adults with post- and precapillary pulmonary hypertension due to heart failure. The Rahway, N.J., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback